Impact of immune suppressive agents on the BK‐Polyomavirus non coding control region
暂无分享,去创建一个
A. Kribben | S. Ciesek | O. Witzke | M. Widera | U. Dittmer | K. Sutter | B. Wilde | Helene Sertznig | O. Anastasiou | J. Verheyen | B. Bleekmann | J. Korth | A. Brinkhoff | Julia Dickow | Nicola Frericks
[1] A. Kribben,et al. Impact of low‐level BK polyomavirus viremia on intermediate‐term renal allograft function , 2018, Transplant infectious disease : an official journal of the Transplantation Society.
[2] J. Pascual,et al. Recommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities. , 2017, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.
[3] J. Fishman. Infection in Organ Transplantation , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[4] H. Walter,et al. HIV-1 persistent viremia is frequently followed by episodes of low-level viremia , 2017, Medical Microbiology and Immunology.
[5] H. Hirsch,et al. Imperfect Symmetry of Sp1 and Core Promoter Sequences Regulates Early and Late Virus Gene Expression of the Bidirectional BK Polyomavirus Noncoding Control Region , 2016, Journal of Virology.
[6] V. Nickeleit,et al. Distinct BK polyomavirus non-coding control region (NCCR) variants in oral fluids of HIV- associated Salivary Gland Disease patients. , 2016, Virology.
[7] H. Hirsch,et al. BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP‐12 , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[8] J. MacKeigan,et al. Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex. , 2015, Neuro-oncology.
[9] P. Reinke,et al. The Loss of BKV‐specific Immunity From Pretransplantation to Posttransplantation Identifies Kidney Transplant Recipients at Increased Risk of BKV Replication , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[10] E. Sausville,et al. Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice , 2015, Proceedings of the National Academy of Sciences.
[11] J. Klawitter,et al. Everolimus and sirolimus in transplantation-related but different , 2015, Expert opinion on drug safety.
[12] Shang-jun Jiang,et al. Dual targeting of mTORC1 and mTORC2 by INK-128 potently inhibits human prostate cancer cell growth in vitro and in vivo , 2015, Tumor Biology.
[13] W. Schaffner,et al. Sp1 Sites in the Noncoding Control Region of BK Polyomavirus Are Key Regulators of Bidirectional Viral Early and Late Gene Expression , 2015, Journal of Virology.
[14] F. Liu,et al. The preclinical evaluation of the dual mTORC1/2 inhibitor INK-128 as a potential anti-colorectal cancer agent , 2015, Cancer biology & therapy.
[15] J. Schaenman,et al. BK virus infection following kidney transplantation: an overview of risk factors, screening strategies, and therapeutic interventions , 2014, Current opinion in organ transplantation.
[16] P. Mischel,et al. mTORC2 in the center of cancer metabolic reprogramming , 2014, Trends in Endocrinology & Metabolism.
[17] Cheng-Huang Shen,et al. Inhibition of BK virus replication in human kidney cells by BK virus large tumor antigen-specific shRNA delivered by JC virus-like particles. , 2014, Antiviral research.
[18] K. Korn,et al. BK viremia and polyomavirus nephropathy in 352 kidney transplants; risk factors and potential role of mTOR inhibition , 2013, BMC Nephrology.
[19] C. H. Rinaldo,et al. The human polyomavirus BK (BKPyV): virological background and clinical implications , 2013, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[20] D. Sabatini,et al. Regulation of mTORC1 and its impact on gene expression at a glance , 2013, Journal of Cell Science.
[21] G. Russ,et al. Polyomavirus BK Replication in De Novo Kidney Transplant Patients Receiving Tacrolimus or Cyclosporine: A Prospective, Randomized, Multicenter Study , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[22] R. Drew,et al. Phylogenetic analysis of the complete genome of 11 BKV isolates obtained from allogenic stem cell transplant recipients in Ireland , 2012, Journal of medical virology.
[23] J. Sipley,et al. Evaluation of a BK virus viral load assay using the QIAGEN Artus BK Virus RG PCR test. , 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[24] D. Kuypers. Management of polyomavirus-associated nephropathy in renal transplant recipients , 2012, Nature Reviews Nephrology.
[25] Nicholas T. Ingolia,et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis , 2012, Nature.
[26] M. Radi,et al. ATP-competitive inhibitors of mTOR: an update. , 2011, Current medicinal chemistry.
[27] D. Muruve,et al. Anti-BK Virus Mechanisms of Sirolimus and Leflunomide Alone and in Combination: Toward a New Therapy for BK Virus Infection , 2010, Transplantation.
[28] K. Baggerly,et al. Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment. , 2010, Blood.
[29] E. Major,et al. Rearranged JC Virus Noncoding Control Regions Found in Progressive Multifocal Leukoencephalopathy Patient Samples Increase Virus Early Gene Expression and Replication Rate , 2010, Journal of Virology.
[30] Y. S. Kim,et al. Everolimus Plus Reduced‐Exposure CsA versus Mycophenolic Acid Plus Standard‐Exposure CsA in Renal‐Transplant Recipients , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[31] B. O'Hara,et al. Unique susceptibility of a human lung carcinoid tumor cell line to infection with BK virus. , 2010, Virus research.
[32] T. Shenk,et al. Rapamycin-Resistant mTORC1 Kinase Activity Is Required for Herpesvirus Replication , 2010, Journal of Virology.
[33] Ethan M Balk,et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. , 2010, Kidney international.
[34] H. Hirsch,et al. Functional analysis of polyomavirus BK non‐coding control region quasispecies from kidney transplant recipients , 2009, Journal of medical virology.
[35] Hans H Hirsch,et al. The decade of polyomavirus BK-associated nephropathy: state of affairs. , 2009, Transplantation.
[36] C. Drachenberg,et al. Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology , 2008, The Journal of experimental medicine.
[37] A. Mehrabi,et al. Sirolimus in renal transplantation. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[38] B. Kahan,et al. BK Virus–Associated Nephropathy in Sirolimus-Treated Renal Transplant Patients: Incidence, Course, and Clinical Outcomes , 2007, Transplantation.
[39] R. Frisque,et al. Stability and Function of JC Virus Large T Antigen and T′ Proteins Are Altered by Mutation of Their Phosphorylated Threonine 125 Residues , 2006, Journal of Virology.
[40] M. Suthanthiran,et al. Polyomavirus-Associated Nephropathy in Renal Transplantation: Interdisciplinary Analyses and Recommendations , 2005, Transplantation.
[41] M. Schnitzler,et al. Incidence of BK with Tacrolimus Versus Cyclosporine and Impact of Preemptive Immunosuppression Reduction , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[42] U. Moens,et al. Polymorphism in the genome of non-passaged human polyomavirus BK: implications for cell tropism and the pathological role of the virus. , 2005, Virology.
[43] J. Papadimitriou,et al. Histological Patterns of Polyomavirus Nephropathy: Correlation with Graft Outcome and Viral Load , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[44] Lin Chen,et al. Transcriptional regulation by calcium, calcineurin, and NFAT. , 2003, Genes & development.
[45] S. Finkelstein,et al. Viral regulatory region sequence variations in kidney tissue obtained from patients with BK virus nephropathy. , 2003, Kidney international.
[46] C. Cubitt. Molecular genetics of the BK virus. , 2002, Advances in experimental medicine and biology.
[47] M. Imperiale,et al. Novel Mechanisms of E2F Induction by BK Virus Large-T Antigen: Requirement of Both the pRb-Binding and the J Domains , 1998, Molecular and Cellular Biology.
[48] S. Günther,et al. Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. , 1994, Virology.
[49] D. R. Dubbs,et al. T antigen and initiation of cell DNA synthesis in a temperature-sensitive mouse line transformed by an SV40ts a mutant and in heterokaryons of the transformed cells and chick erythrocytes , 1978, Somatic cell genetics.